Best ReLEx SMILE eye surgery Clinics and Costs in 2025

Education :Istanbul University, Istanbul Faculty of Medicine September 2004 – July 2010Istanbul University, Istanbul Faculty of Medicine, Department of Orthopaedics, Residency February 2011 - April 2011 Istanbul University, Istanbul Faculty of Medicine, Department of Ophthalmology, Residency August 2011 - March 2016Thomas Jefferson University, Wills Eye Institute, Ocular Oncology Department, Observership August 2012 - September 2012 Turkish Health Ministry, Hakkari State Hospital, Ophthalmology Clinic, Eye M.D July 2016 – March 2018Van Yuzuncu Yil University, Faculty of Medicine, Ophthalmology Department, Assistant Professor, March 2018 – October 2021Van Yuzuncu Yil University, Faculty of Medicine, Ophthalmology Department, Associate Professor, October 2021 – December 2021Istanbul Yeni Yuzyil University, Faculty of Medicine, Ophthalmology Department, Associate Professor, January 2022 – presentEducational Qualifications :1. International Council of Ophthalmology (ICO) Basic Sciences assessment in ophthalmology examination  passed on April 20172. International Council of Ophthalmology (ICO) Optics & Refraction examination passed on April 20173. International Council of Ophthalmology (ICO) Clinical Sciences in Ophthalmology examination passed on April 20184. Awarded for ICO-STAAR Surgical Three-Month Fellowship in Vitreo-Retina at the University of Kansas, Medical School, Dept. of Ophthalmology in Prairie Village, KS, USA under the supervision of Prof. Radwan Aijlan from April 6, 2020, to July 5, 2020.5. International Council of Ophthalmology (ICO) Advanced Examination in Ophthalmology examination passed on July 2020.6. United States Medical Licensing Examination (USMLE) Step 1 passed on January 7 2021 with 221 pts.7. United States Medical Licensing Examination (USMLE) Step 2 CK passed on August 25 2021 with 214 pts.Presentations & Posters :1. 47th National Ophthalmology Congress, The effectiveness of photodynamic therapy on circumscribed choroidal hemangioma, Oral presentation, Ozer MD, Tuncer S, November 2013, Antalya, Turkey. 2. 48th National Ophthalmology Congress, Clinical features and treatment outcomes of primary ophthalmic rhabdomyosarcoma: Tertiary center experience, Ozer MD, Ulas MG, Tuncer S, Oral presentation, November 2014, Antalya, Turkey3. 2015 ISOO Meeting, Long-term Outcome of Combined (Perilesional Injection and Topical) Alpha-2b Therapy in the Management of Ocular Surface Squamous Neoplasia, Tuncer S, Ozer MD, Oral presentation, June 2015, Paris, France4. 49th National Ophthalmology Congress. Clinical presentation patterns of pediatric Vogt-Koyanagi-Harada syndrome and long-term follow-up results, Kiragi D, Ozer MD, Lider-Gezer M, Oray M, Tugal-Tutkun I, Oral presentation, November 2015, Istanbul, Turkey.5. 49th National Ophthalmology Congress, Central corneal thickness and optic disc dimensions in glaucoma patients, Bayraktar S, Ozer MD, Izgi B, Poster, November 2015, Istanbul, Turkey.6. 49th National Ophthalmology Congress, Analysis of retinal nerve fiber layer and choroidal thickness in patients with syic sclerosis to identify a potential risk factor for normal-tension glaucoma, Ceylan E, Ozer MD, Ekinci M, Yilmaz YC, Poster, November 2015, Istanbul, Turkey.7. 50th National Ophthalmology Congress, Treatment of age-related macular degeneration with intravitreal Ranibizumab: Real-life experience, Cebeci Z, Yilmaz YC, Ozer D, Kir N, Oral presentation, November 2016, Antalya, Turkey8. 51st National Ophthalmology Congress, A rarely seen complication of cataract surgery: Endocapsular Hematoma, Ozer MD, Batur M, Artuç T, Seven E, Tekin S, Poster, November 2017, Antalya, Turkey9. 52nd National Ophthalmology Congress, Nanophthalmos Wıth Macular Folds, Yavuzer B, Batur M, Seven E, Ozer MD, Poster, November 2018, Antalya, Turkey10. 52nd National Ophthalmology Congress, Clinical Features and Treatment Methods of Orbital Cellulite Cases, Mesen S, Tekin S, Batur M, Duzenli U, Seven E, Ozer MD, Poster, November 2018, Antalya, Turkey11. 52nd National Ophthalmology Congress, Case Series: Ocular Chemical Burns, Tekin S, Artuç T, Batur M, Ozer MD, Poster, November 2018, Antalya, Turkey12. 52nd National Ophthalmology Congress, Sensory-Neural Hearing Loss affecting Low frequencies in Patients with Pseudoexfoliation, Ozer MD, Batur M, Duzenli U, Seven E, Tekin S, Poster, November 2018, Antalya, Turkey13. 52nd National Ophthalmology Congress, Silicone tube intubation by Ritleng stent in children over two years of age with nasolacrimal duct obstruction, Ocal H, Seven E, Tekin S, Ozer MD, Batur M, Poster, November 2018, Antalya, Turkey14. 52nd National Ophthalmology Congress, Cherry Red Spot Appearance in Macula and Alkaptonuria: A Case Report, Mesen S, Batur M, Ozer MD, Tekin S, Poster, November 2018, Antalya, Turkey15. 52nd National Ophthalmology Congress, A Rare Complication in Intravitreal Dexamethasone Implantation: Implant Migration to the Anterior Chamber, Gulbay S, Batur M, Ozer MD, Tekin S, Poster, November 2018, Antalya, Turkey16. 52nd National Ophthalmology Congress, Effect of Coenzyme Q10 Eye Drop on Corneal Wound Healing in Bacterial Keratitis Treatment, Batur M, Seven E, Tekin S, Ozer MD, Oral presentation, November 2018, Antalya, Turkey17. 19th Euretina Congress, Effect of reduced production of aqueous humor on bacterial growth potential in rabbit eyes, Batur M, Ozer M, Tekin S, Oral presentation, September 2019, Paris, France18. 53rd National Ophthalmology Congress, Evaluation of the clinical features of patients with hyphema due to blunt trauma, Seven E, Kebapci F, Tekin S, Batur M, Ozer MD, Oral presentation, November 2019, Antalya, Turkey19. 53rd National Ophthalmology Congress, Adherence to drop therapy and the relationship of compliance with progression in glaucoma patients, Tekin S, Ocal H, Seven E, Batur M, Ozer MD, Poster, November 2019, Antalya, Turkey20. 53rd National Ophthalmology Congress, Bilateral sudden-transient vision loss after central venous catheter removal, Altas AS, Batur M, Sayir F, Seven E, Tekin S, Ozer MD, Poster, November 2019, Antalya, Turkey21. 53rd National Ophthalmology Congress, Clinical Evaluation of Argon Laser Photocoagulation Therapy in Patients with Retinal Tears, Ocal H, Seven E, Batur M, Tekin S, Ozer MD, Poster, November 2019, Antalya, Turkey 22. 53rd National Ophthalmology Congress, Macular damage due to laser epilation: a case report, Batur M, Ocal H, Ozer MD, Seven E, Tekin S, Poster, November 2019, Antalya, Turkey 23. 53rd National Ophthalmology Congress, Phototoxic Maculopathy Due to Extreme Usage of Infrared Illuminator Assembled Night Vision Handheld Scope, Ozer MD, Batur M, Seven E, Tekin S, Savasan M, Poster, November 2019, Antalya, Turkey 24. 54th National Ophthalmology Congress, Internal Ophthalmolplegia after Chickenpox Infection, Gedik AC, Ozer MD, Poster, November 2020, Virtual, Turkey. Work Experience :1. Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis (SARILNIUSATURN-Sanofi), Sub-Investigator (Principle investigator: Prof. Dr. Ilknur Tugal-Tutkun)2. Efficacy of Gevokizumab in the Treatment of Patients With Behçet's Disease Uveitis (EYEGUARD-A&C-Servier), Sub-Investigator (Principle investigator: Prof. Dr. Ilknur Tugal-Tutkun)3. A Randomized, Double-masked, Placebo-controlled Study of the Efficacy of Gevokizumab in the Treatment of Patients With Behçet's Disease Uveitis (EYEGUARD-B-Servier), Sub-Investigator (Principle investigator: Prof. Dr. Ilknur Tugal-Tutkun) 4. A 12-month, randomized, double-masked, sham-controlled, multicenter study to evaluate the efficacy and safety of 0.5 mg ranibizumab intravitreal injections due to vascular endothelial growth factor (VEGF) driven macular edema (RFB002-Novartis), Injection sub-investigator (Principle investigator: Prof. Dr. Nur Kir)5. A Phase III multicenter, randomized, double-masked, sham-controlled study to assess the efficacy and safety of Lampalizumab administered intravitreally to patients with geographic atrophy secondary to age-related macular degeneration (GX29176-Roche), Photographer (Principle investigator: Prof. Dr. Nur Kir) Selected as an active member of the Turkish Ophthalmological Association, Young Ophthalmologist Council, 2020 - present 

Dr. Jordi Mones is an M.D., Ph.D., Ophthalmologist, Macula, and Vitreorretinal Specialist. He has significantly contributed to the field of ophthalmology, especially in the development of advanced macular degeneration imaging techniques and treatment protocols. He has a special interest in pathophysiology, imaging, and emerging therapies for AMD and retinal degenerative diseases. Education Ph.D. cum laude in Medicine and Surgery, Universitat de Barcelona, Spain.Specialized in Ophthalmology at the Centro de Oftalmología Barraquer, Universitat Autònoma de Barcelona from 1986-1989.Research Retina Fellowship at the Massachusetts Eye and Ear Infirmary at Harvard University, Boston, USA, in 1990 and 1991.Clinical Retina Fellowship at the Hospital San José at the Instituto Tecnológico y de Estudios Superiores de Monterrey, Mexico, in 1992. Awards Research Member Elect of experts in the International Alliance AMD.Scientific adviser to the European Association for Vision and Eye Research.Scientific member of the 2020 European Union Horizon 2020 program EYERISK, DMAE, LITE. Membership Member of 12 scientific societies, including the Macula Society, The Retina Society, The Club Jules Gonin, and The American Society of Retina Specialists.Serves as a Scientific Advisor for several Pharmaceutical and Biotech Companies.

Education Higher education: Medical Faculty of Gazi University, Turkey. Internship: Numune scientific research hospital in Ankara, Turkey. Internship abroad Specialization: Research Fellow, Wills Eye Hospital Cornea Department, Thomas Jefferson University, Philadelphia, USA. Membership in organizations Turkish Ophthalmological Association KRCB (Society of Cataract and Refractive Surgery). ASCRS (American Society of Cataract and Refractive Surgery). ESCRS (The European Society of Cataract and Refractive Surgeons). Turkish Medical Association.